Kramer Levin Naftalis & Frankel LLP
Steven M. Goldman represents clients in connection with mergers and acquisitions, financings, joint ventures, private placements, and leveraged buyouts, as well as in general corporate matters. Mr. Goldman advises boards of directors and independent committees of boards on corporate transactions. He also represents companies in the insurance industry in connection with regulatory enforcement issues and in purchase and sale transactions.
Among his most recent notable work, Mr. Goldman represented PBM Pharmaceuticals Inc., a privately held specialty pharmaceutical company doing business as Revive Pharmaceuticals, in its sale of Donnatal® to Concordia Pharmaceuticals Inc., a subsidiary of Concordia Healthcare Corp. He also led the deal teams in the acquisitions of French toy company Juratoys and its subsidiary brands Janod and Kaloo, two leading European toy brands, and of Hong Kong-based Buzz Bee Toys, a diverse line of active play toys, for the Alex Brands family of children’s creative products. Mr. Goldman’s recent work on behalf of boards of directors includes his representation of an independent committee of the board of directors of Wawa Inc. in connection with the change in the company’s tax structure from a C corporation to an S corporation. He also represented Leading Pharma LLC in its acquisition of substantially all of the assets of Excellium Pharmaceutical Inc., as well as in a private equity offering by Leading’s parent company.
Before joining Kramer Levin in 2009, Mr. Goldman served as the Commissioner of the New Jersey Department of Banking and Insurance, appointed by Gov. Jon S. Corzine. In that role, he chaired the Reinsurance Task Force at the National Association of Insurance Commissioners, which during his tenure completed a framework for modernizing the regulation of reinsurance both in the United States and between the United States and other countries. He also chaired the International Insurance Relations Committee of the NAIC, and the Reinsurance and Other Forms of Risk Transfer Subcommittee on behalf of the U.S. at the International Association of Insurance Supervisors. Mr. Goldman was also one of seven commissioners nationally developing insurance regulatory modernization reform proposals on behalf of the NAIC. Mr. Goldman has testified before Congress on multiple occasions regarding insurance regulation and health care reform.
Mr. Goldman devotes significant time to civic work. President Barack Obama appointed Mr. Goldman to the President's Advisory Committee on the Arts for the John F. Kennedy Center for the Performing Arts in August 2014. He is a member of the board of directors of Macaulay Honors College Foundation at The City University of New York. He is also a member of the board of directors and of the Executive Committee, Chair of the Operations and Finance Committee and Assistant Treasurer of the New Jersey Performing Arts Center, and is a member of the Board of Managers of Theatre Square Development Company, LLC (the real estate development subsidiary of the NJ Performing Arts Center). Mr. Goldman also serves as a member of the advisory group to the American Law Institute in connection with the development of the Restatement of the Law of Liability Insurance. He served for 13 years on the Board of Directors of Holy Name Medical Center in Teaneck, New Jersey, and also as the hospital’s outside counsel in numerous matters. He serves on the Dean’s Board of Advisors for The George Washington University Law School and as Chair of its Business and Finance Law Advisory Board, as well as on the U.S. Trust Northeast Client Advisory Council. Mr. Goldman is a member of the Economic Club of New York and the Lotos Club, and serves as the firm’s liaison to the Partnership for New York City.
In the for-profit sector, Mr. Goldman serves as a board member for Bank Leumi USA Inc.; Hi-Touch Business Services, a leading supplier of office supplies and related products on a business-to-business basis; Propel Equity Partners, a private equity firm focused on creating value in leading consumer brands; and Leading Pharmaceuticals LLC.